International Conference on Challenges in Liver Disease Honors World-Renowned Hadassah Liver Specialist
About 200 health professionals--including 20 of the world's leading liver specialists from France, Germany, Israel, Italy, the United Kingdom, and the United States--attended an international conference on liver disease at the Hadassah Medical Center in January, where they honored Hadassah's Prof. Daniel Shouval upon his 70th birthday.
Prof. Daniel Shouval
In 1983, Prof. Shouval established the first liver unit in Israel at Hadassah, which he directed for almost 30 years until his recent retirement. During his very long career at the Medical Center, Prof. Shouval was responsible for many breakthroughs, created generations of fine liver experts, and published many pivotal research papers. The new head of Hadassah's Liver Unit, Dr. Rifaat Safadi of Nazareth, had worked alongside Dr. Shouval for 20 years.
"Diagnosis and treatment of liver diseases has made very significant progress in recent years," notes Prof. Shouval. "Israel is among the most advanced countries in the world in preventing and treating viral liver diseases." Prof. Shouval's research and involvement were most influential in a decision by the Israeli government in 1999 to introduce a full-scale national vaccination program for babies against Hepatitis B. This led to a 95 percent decline in Hepatitis B for adults in Israel. Israel was among the first 10 countries worldwide to institute this program.
A former Dean of the Hadassah-Hebrew University Faculty of Medicine, Prof. Shouval currently serves as a professor of medicine at Hebrew University and a visiting professor at the Yeshiva University's Albert Einstein College of Medicine in New York. During his career, he has held similar positions at the Harvard Medical School and Massachusetts General Hospital in Boston and the University of Paris in France, and worked in several liver research centers in the United Kingdom, France, and the United States.
Prof. Shouval is the recipient of several national and international awards and the author of over 200 articles and chapters in medical text books. He served as President of the European Association for the Study of the Liver and Chairman of the Educational Committee of the European Association for the Study of the Liver. In this capacity, he became involved in education about Hepatology and the prevention of liver disease worldwide.
A permanent adviser to the European Viral Hepatitis Prevention Board and the World Health Organization, Prof. Shouval was Associate Editor of The Journal of Liver Transplantation and a member of the editorial boards of several leading hepatology journals.
The Conference, entitled "New Challenges in the Diagnosis and Treatment of Liver Diseases," was sponsored by Hadassah, the Hebrew University, and the European and Israeli societies for study of the liver.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>